A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB)

Hormone traces in aquaculture tank water offer a less intrusive way to monitor the health of popular Asian fish farm stocks.

Cell and gene therapies are driving the next revolution in medicine, combining the best of biology with game-changing technologies from A*STAR researchers and partners.

Researchers uncovered how specialised stem cells act as building blocks for the esophagus, shaping its development and offering insights into treating related diseases.

A comprehensive study of liver tumours reveals that a small fraction of aggressive cells can have an outsized effect on patient outcomes.

High iron levels, often linked to red meat consumption, can fuel cancer growth by reactivating proteins that allow cancer cells to divide endlessly.

A new wearable sensor continuously detects key chemical biomarkers directly from the skin, circumventing more invasive clinical methods.

A new sensor innovation measures stress inside tissue models to simulate disease conditions like cancer with greater accuracy.

A deeper look at nanoparticle design reveals how customised lipid carriers with advanced structures can greatly enhance the delivery of mRNA treatments.

In recognition of their scientific contributions and impact both locally and globally, 14 leading researchers have been awarded the 2024 A*STAR Fellowship.

Through its focus on attracting, developing and retaining talents in science and technology, A*STAR is helping to build a rich national ecosystem of research, innovation and enterprise.

A comprehensive genomic map reveals how certain genes regulate key cells in blood sugar control, offering new insights for future diabetes treatments.

Researchers developed a new method to improve the effectiveness of islet cell transplants, which may offer better treatment options for people with diabetes.